Axogen (AXGN)Chief Innovation Officer sold ~$264K

~$264K

Approx. value · 15K sh @ $17.50

218K

Holds after · shares reported

Traded

Mar 19, 2025

Filed

Mar 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 3, 2025InsiderDirector sold ~$100K of AXGN shares in the open market
2. Mar 19, 2025 · this disclosureInsiderOfficer sold ~$264K of AXGN shares in the open market

What came next

1. May 19, 2025InsiderDirector sold ~$29K of AXGN shares in the open market
2. May 22, 2025Insider · 1 personInsiders: 2 sales (~$225K)
3. Jun 9, 2025Insider · 6 peopleInsiders: 6 sales (~$259K)
4. Jun 10, 2025InsiderDirector sold ~$289K of AXGN shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Axogen

For Axogen, OQRO holds 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AXGN page.

Other recent filings by Erick Wayne Devinney, Chief Innovation Officer

• SEC Form 4 at Axogen (AXGN)Sep 16, 2025

The full history of Erick Wayne Devinney, Chief Innovation Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Axogen

• SEC Schedule 13GOct 2, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its AXGN page.